š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The study is being conducted to evaluate the efficacy, and safety of camrel...
Status
Unknown
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2022-09-08
Trial ID
NCT05042375
Treatments Being Tested
This is a single-center, randomized, open-label study to compare the pharma...
Status
Completed
Location
Xiangya Hospital Central South University
Start Date
2021-09-23
Trial ID
NCT05046808
Famitinib is a novel oral multitargeted tyrosine kinase inhibitor with anti...
Status
Completed
Location
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Start Date
2009-06
Trial ID
NCT01762280
Treatments Being Tested
The study is a single-centre, randomized, open, 2-period, 2-sequence crosso...
Status
Completed
Location
The First Affiliated Hospital of USTC
Start Date
2022-05-11
Trial ID
NCT05336279
To assess the safety and tolerability of SHR-1802 combined with camrelizuma...
Status
Terminated
Location
Tianjin Medical University Cancer Institute&Hospital
Start Date
2022-04-22
Trial ID
NCT05208177
Treatments Being Tested
This is a phase II, open-label, multi-cohort study, aiming to investigate s...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2021-09
Trial ID
NCT05005468
Treatments Being Tested
The primary objective is to evaluate the bioequivalence of famitinib malate...
Status
Completed
Location
Xuanwu Hospital Beijing, Capital Medical University
Start Date
2020-05-27
Trial ID
NCT04400123
Treatments Being Tested
This is a randomized, open-label, international, multi-center, phase III tr...
Status
Terminated
Location
Subei People's Hospital of Jiangsu Province
Start Date
2022-01-06
Trial ID
NCT05106335
Treatments Being Tested
The study is being conducted to evaluate safety, tolerability and prelimina...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2022-08-12
Trial ID
NCT05214976
Phase II multi-chort, adaptive two-stage, open label, nonrandomized study. ...
Status
Unknown
Location
Huadong Hospital Affiliated to Fudan University
Start Date
2019-01-23
Trial ID
NCT03827837